Madaswamy S. Muthu

M.S. Muthu (born 20 July 1981) is a pharmaceutical engineer, scientist, inventor and one of the nineteen institute professors at the Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU).^[1] He is a researcher in the field of nanomedicine, targeted drug delivery and theranostics nanomedicine for therapy and imaging.^[2] Dr. Muthu has completed his Ph.D. research work under the supervision of Prof. Sanjay Singh from Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi, India. He has done his post-doctoral research in Cancer Nanotechnology under the supervision of Prof. Feng Si-Shen from the National University of Singapore in 2010 & 2014 (2yrs). Dr. Muthu is an Associate Professor of Pharmaceutics in the Department of Pharmaceutical Engineering & Technology, IIT(BHU).^[1]

M.S. Muthu
Born	(1981-07-20) 20 July 1981 (age 41) India
Alma mater	Indian Institute of Technology (BHU), BITS-Pilani
Known for	Cancer nanotechnology, Targeted drug delivery, Theranostics
Scientific career
Institutions	Indian Institute of Technology (BHU), Varanasi, India
Website	iitbhu.ac.in/dept/phe/people/msmuthuphe

He is a widely recognized and cited researcher in drug delivery especially in the fields of nanotechnology and theranostics. His research work is mainly focused on targeted and/or theranostic drug delivery of anti-cancer drugs, antipsychotics, antithrombotics and antimicrobials.^[2][3] He is the editor in chief for international peer reviewed journal ''Research & Reviews: Journal of Pharmacology and Toxicological Studies''.^[4] Additionally, he is the editorial board member of the "Diagnostics and Therapeutics" Journal published by Luminescience press is based in Hong Kong with offices in Wuhan and Xi’an, China. He is among the top 2% scientist globally, list compiled by the Stanford University.^[5][6] His profile has been listed at the 7th Rank in IIT BHU as per Adscientific index.^[7]

He has received more than 12 awards form government and non-government organization.^[8] He is the recipient of the BIRAC-DBT-Gandhian Young Technological Innovation (GYTI) Award in 2017, from the president of India for advancing nanomedicine research.^[9] He has received a BOYSCAST fellowship from the Department of Science and Technology (DST), India and received CREST Award from the Department of Biotechnology (DBT), India.  He has received IMS-Research Publication Award for three years. Dr. Muthu has also received the Vice-Chancellor's Medical Research Award, BHU and International Faculty Award (VIFA-2016), India.^[10] His research work has secured Rs. 2.19 Crores fund from various government funding agencies that includes SERB, DST, DBT, ICMR India, BIRAC and DBT-IC. He has been elected as a Member of the National Academy of Sciences, India (NASI) in 2019. Additionally, he is a fellow of Royal Society of Chemistry (FRSC). His student has received the 2nd Prize for presentation in the Institute Day, IIT (BHU) in 2017. Recently, he has developed targeted nanomedicine for breast cancer therapy with reduced systemic toxicity, which has successfully demonstrated its efficacy in preclinical studies.^[11]

References

1. Muthu, MS. "List of faculties member, Department of Pharmaceutical Engineering (IIT BHU)". IIT BHU. Retrieved 11 October 2020.{{cite web}}: CS1 maint: url-status (link)
2. Muthu, MS. "Google Scholar". Retrieved 11 October 2020.{{cite web}}: CS1 maint: url-status (link)
3. Muthu, MS. "Semantic Scholar". Retrieved 11 October 2020.{{cite web}}: CS1 maint: url-status (link)
4. "Research & Reviews | Pharmacology and Toxicological Studies | Ope". www.rroij.com. Retrieved 2020-10-19.
5. "14 scientists from IIT-BHU in world's top 2 pc scientists' list by Stanford University - Times of India". The Times of India. Retrieved 2020-11-17.
6. "14 scientists from IIT-BHU in world's top 2% scientists' list by Stanford University". Deccan Herald. 2020-11-11. Retrieved 2020-11-17.
7. "World Scientist and University Rankings 2021 - AD Scientific Index 2021". www.adscientificindex.com. Retrieved 2021-08-04.
8. Nascent approaches for nanotech outreach. "25th Nano Congress for Future Advancements". Retrieved 11 October 2020.{{cite web}}: CS1 maint: url-status (link)
9. "BIRAC-SRISTI Awards-2017". Retrieved 11 October 2020.{{cite web}}: CS1 maint: url-status (link)
10. "M. S. Muthu - Facts | VIFA 2016". vifa.info. Retrieved 2022-01-22.
11. Govind. "आईआईटी बीएचयू का झींगे से स्तन कैंसर की दवा बनाने का दावा". Hindustan. Retrieved 11 October 2020.{{cite news}}: CS1 maint: url-status (link)